News from aicuris gmbh & co. kg
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
08 May, 2014, 16:04 BST AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients
AiCuris and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical...
27 Nov, 2012, 08:00 GMT After License Deal for Letermovir: Head-to-head Phase 2 Trial Initiated by AiCuris to Demonstrate Superiority of its Novel Drug Pritelivir vs. Valacyclovir for Treatment of Genital Herpes
Cross-Reference: More Informations are available at: http://www.presseportal.de/pm/106935/ AiCuris announced today that it has started the second...